IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q1 2021 Holdings

Filed 2021-05-17 | 4 holdings | $435.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$407.9K2,253,52893.8%
Novavax, Inc.(NVAX)COM670002401$12.2K67,3732.8%
Epizyme, Inc.(EPZMEUR)COM29428V104$8.7K1,000,0022.0%
Acceleron Pharma Inc.(XLRN)COM00434H108$6.2K45,8841.4%